Landos Biopharma, Inc. Current Ratio 2021-2024 | LABP
Landos Biopharma, Inc. current ratio from 2021 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Current Ratio Historical Data |
Date |
Current Assets |
Current Liabilities |
Current Ratio |
2024-03-31 |
$0.03B |
$0.01B |
4.43 |
2023-12-31 |
$0.04B |
$0.01B |
6.09 |
2023-09-30 |
$0.04B |
$0.01B |
7.77 |
2023-06-30 |
$0.05B |
$0.00B |
15.35 |
2023-03-31 |
$0.05B |
$0.00B |
12.30 |
2022-12-31 |
$0.05B |
$0.01B |
7.39 |
2022-09-30 |
$0.05B |
$0.01B |
9.04 |
2022-06-30 |
$0.06B |
$0.01B |
8.92 |
2022-03-31 |
$0.08B |
$0.02B |
4.99 |
2021-12-31 |
$0.09B |
$0.02B |
5.55 |
2021-09-30 |
$0.10B |
$0.01B |
9.40 |
2021-06-30 |
$0.12B |
$0.01B |
9.40 |
2021-03-31 |
$0.11B |
$0.01B |
12.44 |
2020-12-31 |
$0.03B |
$0.01B |
2.71 |
2020-09-30 |
$0.00B |
|
0.00 |
2020-06-30 |
$0.00B |
|
0.00 |
2020-03-31 |
$0.00B |
|
0.00 |